Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy

por Tang, Jack Pengfei, Peters, Cole W., Quiros, Crystal, Wang, Xiaoyan, Klomhaus, Alexandra M., Yamada, Reiko E., Timmerman, John M., Moore, Theodore B., Nowicki, Theodore S.
Publicado 2022

IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma

por Klingbeil, Kyle D., Tang, Jack Pengfei, Graham, Danielle S., Lofftus, Serena Y., Jaiswal, Amit Kumar, Lin, Tasha L., Frias, Chris, Chen, Lucia Y., Nakasaki, Manando, Dry, Sarah M., Crompton, Joseph G., Eilber, Fritz C., Rao, Dinesh S., Kalbasi, Anusha, Kadera, Brian E.
Publicado 2023